JAS works seamlessly with payors nationwide, to provide cost effective and clinically proven ROM therapy. Only JAS offers a complete portfolio of state-of-the-art adjunctive ROM therapy options – JAS SPS, JAS EZ, JAS GL (for international markets), JAS Dynamic, and Advance Dynamic ROM – to address the unique rehab needs of every patient and insurance plan.

Dramatically reduced treatment time, coupled with proven results make JAS ROM therapy an optimal choice for patients challenged with motion loss.  Our goal – like yours – is to expedite a patient’s return to full function and health.

Need More Reasons to Choose JAS?

Superior Product Design
The patented product design features – available only from JAS – offer comfort, ease of use, patient-controlled therapy, and short treatment time – fostering unmatched patient compliance and delivering superior clinical outcomes.

Evidence Based Results
Successful JAS ROM therapy results – including obviating the need for costly surgical intervention for arthrofibrosis – are proven in over 30 peer-reviewed, published studies. Explore our Research and Resources section

Unmatched Patient Service
With over 280 trained JAS field representatives, JAS offers comprehensive, nationwide coverage including: device delivery, fitting and application assistance, patient education, ongoing follow-up throughout the entire course of therapy, and device retrieval. JAS also offers full time (8AM – 5 PM CST) telephonic tech support for all customers.

Explore the rest of this section to learn how JAS is delivers clear cost benefits, increases patient patient compliance and outcomes, and is the right fit for workers’ comp concerns.

Back to Work, Back to Life™ means Faster, Earlier, Sooner … With Reduced Costs!

With the use of JAS ROM therapy, an injured worker is able to regain functional ROM faster, to be discharged from therapy earlier, and return to full duty work sooner. The result is a huge positive impact on patient compliance, cost savings and therapeutic outcomes. Our goal, like yours, is to expedite an injured worker’s restoration of full function and return to their full duty job demands.

Joint range of motion (ROM) loss directly correlates to the inability to perform activities that are required for an injured worker to return to full duty work. Ultimately, ROM loss can impact a disability claim: ROM is a key measure to determine an injured worker’s settlement. Studies show the use of JAS restores more motion, therefore reducing employers’ costs.

JAS offers unmatched service with quick turnaround time to get your patients moving and back to work. Our JAS customer service team works efficiently to process orders, and our trained field representatives provide comprehensive service including JAS ROM device delivery, fitting, patient education and ongoing follow-up.

JAS Delivers On Outstanding Patient Satisfaction

Patient satisfaction with treatment correlates directly to increased patient compliance, and patient compliance is key to successful clinical outcomes. JAS delivers compliance AND outcomes

A 10-year prospective analysis (Sodhi et al, 2018) of 6000 patients treated with a JAS ROM therapy device showed a significant and consistent improvement in reported patient satisfaction over time – as measured by improved pain, stiffness, swelling and mobility. Study data suggests that JAS’ commitment to continuous improvement in product design and service is directly related to continuous improvement in patient outcomes.

The patented product design features  – available only from JAS – offer comfort, ease of use, patient-controlled therapy, and short treatment time – fostering unmatched patient compliance and delivering superior clinical outcomes. 

Reduce Payor Costs with JAS

Reduce Rehab Costs with JAS

Patients utilizing JAS achieve maximal ROM gains with approximately 2.5 months of device use. JAS users are discharged from therapy earlier, and present with no loss of ROM upon one year follow-up. The average PT or OT visit costs over $400.00 per session and continuing therapy due to persistent ROM loss can become costly to the payor. 1 month of JAS averages under $300/month, less than the cost of an average single therapy visit. Using JAS represents significant cost savings to insurers AND reduced financial burden to employers. Read more about controlling the costs of rehabilitative care here.

Reduce DME Costs with JAS Bidirectional Devices

JAS SPS devices are bidirectional, allowing ROM therapy in two directions of joint motion with one device. Most competitive splint brands work in one direction only – requiring two devices for patients with bidirectional ROM loss – doubling device costs and prolonging rehab.

Prevent the Need for Corrective Surgery with JAS

Arthrofibrosis, if not responsive to conservative therapy, can necessitate additional and costly surgery such as lysis of adhesions or manipulation under anesthesia. Published studies show that JAS SPS knee therapy can restore knee joint motion and eliminate the need for manipulation under anesthesia for patients with arthrofibrosis (Foran et al, 2018, Bonutti et al 2010). SPS elbow therapy was shown to eliminate the need for release surgery in over 75% of chronic elbow stiffness patients (Doornberg et al 2006).